 TEL AVIV, Israel, June 10, 2021 PRNewswire -- Chemomab Therapeutics, Ltd. Nasdaq: CMMB, a clinical-stage biotech company focused on the discovery and development of innovative therapeutics for fibrosis-related diseases with high unmet need, today announced a poster presentation at the International Liver Congress 2021 EASL, which is being held virtually on June 23-26, 2021. 